BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2478705)

  • 21. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
    Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI
    Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M; Kohzu H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of a single antibody RIA assay for alpha-fetoprotein.
    Needleman SB; Goldstein AI; Johnson AM; Golubjatnikov R; Ward AM; Fifield R
    J Reprod Med; 1980 Sep; 25(3):101-7. PubMed ID: 6159471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of MSAFP screening on genetic services, 1984-1986.
    Greenberg F
    Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD; Owen J; Davis RO; Brumfield CG
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
    Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V
    Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
    Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
    J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal serum alpha-fetoprotein screening after chorionic villus sampling.
    Sigler ME; Colyer CR; Rossiter JP; Dorfmann AD; Jones SL; Schulman JD
    Obstet Gynecol; 1987 Dec; 70(6):875-7. PubMed ID: 2446224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
    Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM
    J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal smoking during pregnancy and false positive maternal serum alpha-fetoprotein (MSAFP) screening for open neural tube defects.
    Urato AC; Quinn R; Pulkkinen A; Craigo SD; Allan W
    Prenat Diagn; 2008 Aug; 28(8):778-80. PubMed ID: 18551721
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.
    Burton BK
    Obstet Gynecol; 1988 Nov; 72(5):709-13. PubMed ID: 2459638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
    Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
    Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal serum markers levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels.
    Dar H; Merksamer R; Berdichevsky D; David M
    Am J Med Genet; 1996 Jan; 61(2):154-7. PubMed ID: 8669443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
    Milunsky A; Sapirstein VS
    Obstet Gynecol; 1982 Jan; 59(1):1-5. PubMed ID: 6176922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.